What Happened?. Shares of global pharmaceutical company Merck (NYSE. MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to "Overweight" from "Equal-Weight," citing confidence in the company's future ... More News. ViewMore ... .
MRK) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.7% year on year to $17.28 billion ... Merck (MRK) Q3 CY2025 Highlights. ... MRK) develops and sells prescription medicines, vaccines, ...
Global pharmaceutical company Merck (NYSE. MRK) will be reporting earnings this Thursday morning. Here’s what you need to know ... Is Merck a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members ... More News ... .
What Happened?. Shares of global pharmaceutical company Merck (NYSE. MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers ... and Europe ... More News. ViewMore ... Via MarketBeat ... .
What Happened?. Shares of global pharmaceutical company Merck (NYSE. MRK) jumped 5.7% in the afternoon session after the company announced positive results from its Phase 3 HYPERION trial for its drug, WINREVAIR™ (sotatercept-csrk) ... More News. View More.